How can big pharma bring the most value to new and innovative research and match the rapid pace of biotech labs? How can companies successfully "blend" their expertise, resources and marketing strategies to deliver greater value to their pipelines and their patients?
From evaluations and forecasts to shared missions and gut instincts, join a panel of senior dealmakers from the pharma, biotech and VC communities to learn which factors they weigh most heavily in forming successful collaborations.
Ability Level: All
Session ID: 503652